Literature DB >> 6157757

From the National Institute of Allergy and Infectious Diseases. Update on clinical trials with exogenous interferon.

J K Dunnick, G J Galasso.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157757     DOI: 10.1093/infdis/142.2.293

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

2.  Interferon in acute viral infections.

Authors:  S Levin
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

3.  Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus.

Authors:  J Portnoy; R Hicks; F Pacheco; L Olson
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

Review 4.  Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.

Authors:  K G Nicholson
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

5.  Mechanisms of fever induced by recombinant human interferon.

Authors:  C A Dinarello; H A Bernheim; G W Duff; H V Le; T L Nagabhushan; N C Hamilton; F Coceani
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

6.  Augmentation of endotoxin fever by recombinant human beta interferon in rabbits.

Authors:  H Kawasaki; M Moriyama; A Tanaka
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 7.  Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.

Authors:  Seidu A Richard
Journal:  Mediators Inflamm       Date:  2021-01-07       Impact factor: 4.711

8.  Chapter 3 Antiviral drugs: general considerations.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.